Acute myeloid leukemia

Margaret R. O'Donnell, Camille N. Abboud, Jessica Altman, Frederick R. Appelbaum, Daniel A. Arber, Eyal Attar, Uma Borate, Steven E. Coutre, Lloyd E. Damon, Salil Goorha, Jeffrey Lancet, Lori J. Maness, Guido Marcucci, Michael M. Millenson, Joseph O. Moore, Farhad Ravandi, Paul J. Shami, B. Douglas Smith, Richard M. Stone, Stephen A. StricklandMartin S. Tallman, Eunice S. Wang, Maoko Naganuma, Kristina M. Gregory

Research output: Contribution to journalReview article

181 Scopus citations

Abstract

Acute myeloid leukemia (AML) remains the most common form of acute leukemia among adults and accounts for the largest number of annual deaths due to leukemias in the United States. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for AML provide recommendations on the diagnostic evaluation and workup for AML, risk assessment based on cytogenetic and molecular features, treatment options for induction and consolidation therapies for younger and older (age ≥ 65 years) adult patients, and key supportive care considerations.

Original languageEnglish (US)
Pages (from-to)984-1021
Number of pages38
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume10
Issue number8
Publication statusPublished - Aug 1 2012
Externally publishedYes

    Fingerprint

ASJC Scopus subject areas

  • Oncology

Cite this

O'Donnell, M. R., Abboud, C. N., Altman, J., Appelbaum, F. R., Arber, D. A., Attar, E., ... Gregory, K. M. (2012). Acute myeloid leukemia. JNCCN Journal of the National Comprehensive Cancer Network, 10(8), 984-1021.